ACIP review of the hepatitis B birth dose vaccination remains a grave concern - Please read more here.

Site Search

You searched for "hepatitis D"

  • The Making of A State Viral Hepatitis Elimination Plan - The Budget

    In Pennsylvania, the Hepatitis B Foundation is collaborating with various stakeholders to launch a State Viral Hepatitis Elimination Plan! Join us as we document our process from start to finish! This month's installment focuses on speaking with state legislators to ask for funding to support elimination.

    http://www.hepb.org/blog/making-state-viral-hepatitis-elimination-plan-budget/
  • Behind the Scenes of A Viral Hepatitis Elimination Plan in Pennsylvania

    In Pennsylvania, the Hepatitis B Foundation is collaborating with various stakeholders to launch a State Viral Hepatitis Elimination Plan! Join us as we document our process from start to finish! In this video, Michaela Jackson, MS recounts the Hepatitis B Foundation's attendance to the first ever State Viral Hepatitis Elimination Stakeholder Planning Meeting! The meeting, which was hosted by the Pennsylvania Department of Health, brought awareness and education to the state's lawmakers!

    http://www.hepb.org/blog/behind-scenes-viral-hepatitis-elimination-plan-pennsylvania/
  • Celebrating Hepatitis Awareness Month with a State Hepatitis Elimination Plan

    In Pennsylvania, the Hepatitis B Foundation is collaborating with various stakeholders to launch a State Viral Hepatitis Elimination Plan! Join us as we document our process from start to finish!

    http://www.hepb.org/blog/making-state-viral-hepatitis-elimination-plan/
  • Beating the Odds: A Liver Cancer Survivor's Story

    Liver cancer, caused by hepatitis B and C, is on the rise in the U.S. and it is also the second deadliest. Fewer than 15 percent of patients with liver cancer will survive five years after their diagnosis. It is the third-leading cause of cancer deaths among Asian-Americans and the eighth-leading cause of cancer deaths among Caucasian-Americans. Despite this bleak outlook, there are people with liver cancer who are beating the odds and surviving. The medical community is also working hard to develop new drugs and effective strategies to treat liver cancer. Here is one survivor's story. By Frank Gardea Image courtesy of David Castillo Dominici at FreeDigitalPhotos.net In late 2008, during routine testing before surgery, I found out I had hepatitis C and liver cirrhosis. It was a double whammy because having both viral hepatitis and cirrhosis put me at high risk for liver cancer. Then the abdominal pain started. I suffered for almost three years and was in and out of the emergency department. They could not pinpoint the cause of the pain. When they finally diagnosed my liver cancer, the tumor was over 8 cm in size. I was of course angry. Why didn’t they catch my cancer earlier? I was hospitalized for over a week and then referred to the oncology department. That’s when they told me, “You have three months to live.” I was not a candidate for a liver transplant and one of the doctors didn’t even want to give me a referral to a hepatologist because she thought I was too far gone.  I went home and binge-watched YouTube videos on liver cancer. I found out that far too often, by the time liver cancer is diagnosed, it’s too late. Another doctor later referred me to UCLA, one of the top liver cancer centers in the country. At my first appointment at the liver cancer center, I saw Dr. Richard Finn, a leading liver cancer expert, who was part of a team of health care professionals taking care of me. They never once said I was beyond hope. The following week,

    http://www.hepb.org/blog/beating-the-odds-a-liver-cancer-survivors-story/
  • Clinical Trials in Liver Cancer: What You Need to Know

    Myth: Clinical trials are only for people with advanced stages of cancer. Fact: No! Trials are available for all stages of cancer, not just for people who have advanced cancer that is not responding to treatment. If you or a loved one needs treatment for liver cancer, clinical trials are an option to think about. Clinical trials are essential for developing new ways to prevent, detect, and treat cancer. Researchers run clinical trials to find out whether new treatments are safe and effective and work better than current treatments. When you take part in a clinical trial, you add to our knowledge about cancer and help improve cancer care. Myth: My doctor decides whether I should participate in a clinical trial. Fact: No! You (or the person who needs cancer treatment) decide whether to participate in the trial. Your health care team, including your doctors, will give you the information you need to help you make the decision. That's why it's important for you to  understand what trials are and how they work. What does participation in a trial involve? What are your rights and responsibilities? And what happens after the trial has ended? Join the Hepatitis B Foundation’s free webinar “Clinical Trials in Liver Cancer” to learn the answers to these questions. Developed by Liver Cancer Connect, the Hepatitis B Foundation’s liver cancer program, in collaboration with The Center for Information and Study on Clinical Research Participation (CISCRP), and Blue Faery: The Adrienne Wilson Liver Cancer Association, the webinar will explain what you need to know to help you decide about participating in a trial. Please register to join the conversation on Wednesday, May 27 at 1:30 pm US Eastern Time.  

    http://www.hepb.org/blog/clinical-trials-in-liver-cancer-what-you-need-to-know/